Reporter June 9 2017
STINGing combination for cancer
Jun. 19, 2017—A novel immunotherapy combination induced remarkable regression of tumors in a mouse model of head and neck cancer.
PET imaging to predict tumor response
Jun. 14, 2017—A PET probe that detects the amino acid glutamine predicts whether tumors respond to certain targeted therapies in preclinical animal models.
Repriming replication roadblocks
Jun. 12, 2017—New findings shed light on how enzymes that replicate DNA skip over mutations that might cause cancer and restart DNA synthesis further away.
Flip side of gut protection
Jun. 9, 2017—Vanderbilt investigators report that dysregulation of certain immune cells in the intestines may lead to inflammation and disease.
VUSM joins initiative to transform medical education
Jun. 8, 2017—Vanderbilt University School of Medicine (VUSM) has been chosen to be a part of the newly formed Robert D. and Patricia E. Kern Institute for the Transformation of Medical Education (Kern Institute), a national initiative to transform medical education across the continuum from pre-medical school to physician practice.
New clinic focuses on patients with rare ear malformations
Jun. 8, 2017—Having a child born without an external ear or ear canal can be a scary and confusing experience for parents, and finding medical care for the rare condition has meant having to travel to several distant medical centers for treatment options.
New internship programs set to benefit diverse group of students
Jun. 8, 2017—This summer, Vanderbilt University Medical Center (VUMC) will be the site for two internship programs geared to connect diverse students interested in health care.
Three teams take top prizes at inaugural innovation challenge
Jun. 8, 2017—Last week, Vanderbilt’s Department of Radiology and Radiological Sciences hosted the inaugural RadX Innovation Challenge Pitch Event.
Pal to lead VICC Cancer Health Disparities program
Jun. 8, 2017—Clinical geneticist Tuya Pal, M.D., has joined Vanderbilt-Ingram Cancer Center (VICC) as associate director of Cancer Health Disparities. Pal also has been named an associate professor of Medicine and Ingram Associate Professor of Cancer Research.
VUMC lands renewal of Clinical and Translational Science Award
Jun. 8, 2017—Vanderbilt University Medical Center (VUMC) has competed successfully for a second renewal of its Clinical and Translational Science Award (CTSA) by the National Institutes of Health (NIH).
Coffey lands major NCI award to support colorectal cancer research
Jun. 8, 2017—Vanderbilt’s Robert Coffey Jr., M.D., has received an Outstanding Investigator Award from the National Cancer Institute (NCI) — more than $6.6 million over seven years — to support studies aimed at advancing the diagnosis and treatment of colorectal cancer (CRC), a leading cancer killer.
NIDDK renews Vanderbilt’s diabetes research grant
Jun. 8, 2017—The Vanderbilt Diabetes Research and Training Center (VDRTC) is celebrating its 44th year of operation with a five-year competitive renewal of its $9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH).
